Pricing Log in Create free account

Azora Therapeutics, Inc. (AZR) vs Palatin Technologies, Inc. (PTN)

Azora Therapeutics, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Azora Therapeutics, Inc. and Palatin Technologies, Inc. are of similar size ($10.2M and $9.7M). Azora Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. Azora Therapeutics, Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Azora Therapeutics, Inc. leads on 7 and Palatin Technologies, Inc. on 4.

Valuation

Metric AZR PTN Biotechnology median
P/E n/m 12.21 10.26
P/S n/m 1.23 9.18
P/B n/m 2.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.19 n/m 0.65
EV/Sales n/m 0.67 8.98
Earnings yield (433.06%) 8.19% (34.89%)
Free cash flow yield (62.39%) (83.75%) (24.52%)

Profitability

Metric AZR PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity 352.60% (877.60%) (50.12%)
Return on assets (322.10%) (142.11%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AZR PTN Biotechnology median
Revenue growth (TTM) — 110.89% 6.26%
EPS growth (last fiscal year) 82.46% 90.80% 29.88%
Revenue growth, 5-year CAGR — 156.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AZR PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 4.61 4.89
Net debt to EBITDA 0.75 0.87 1.01

Dividend

Metric AZR PTN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZR PTN Biotechnology median
Market cap 9.74m 10.17m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack